Evidence map›Paper›PMID 34593607›Full record

ArticleMolecular cancer research : MCR2022

Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.

Tshering D Lama-Sherpa, Shamik Das, Dominique C Hinshaw, Sarah C Kammerud, Patrick N Song, Heba A Alsheikh, Anna G Sorace, Rajeev S Samant, Lalita A Shevde

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tshering D Lama-SherpaDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0003-2057-1962
Shamik DasDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.
Dominique C HinshawDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.
Sarah C KammerudDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-4808-1618
Patrick N SongDepartment of Radiology, The University of Alabama at Birmingham, Birmingham, Alabama.
Heba A AlsheikhDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-7006-5294
Anna G SoraceDepartment of Radiology, The University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-3640-3966
Rajeev S SamantDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0001-5681-4976
Lalita A ShevdeDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama. lalitasamant@uabmc.edu.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Personalizing immunotherapy in HER2+ breast cancer through quantitative imagingR01CA240589 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SORACE, ANNA C · 2020 to 2023
$1.6M
Molecular determinants of breast cancer malignancyR01CA138850 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SHEVDE, LALITA A. · 2011 to 2015
$1.6M
Mechanisms of resistance to cancer therapeuticsR01CA169202 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHEVDE, LALITA A. · 2014 to 2018
$1.5M
Mechanisms that impact metastatic progression of triple negative breast cancerI01BX003374 · VA · BIRMINGHAM VA MEDICAL CENTER · PI SAMANT, RAJEEV S · 2017 to 2024
–
BLRD VA I01 BX003374NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA138850NCI NIH HHS R01 CA169202NCI NIH HHS R01 CA240589NIAID NIH HHS T32 AI007051
6 · The paper itself

Abstract

Metastases account for the majority of mortalities related to breast cancer. The onset and sustained presence of hypoxia strongly correlates with increased incidence of metastasis and unfavorable prognosis in patients with breast cancer. The Hedgehog (Hh) signaling pathway is dysregulated in breast cancer, and its abnormal activity enables tumor progression and metastasis. In addition to programming tumor cell behavior, Hh activity enables tumor cells to craft a metastasis-conducive microenvironment. Hypoxia is a prominent feature of growing tumors that impacts multiple signaling circuits that converge upon malignant progression. We investigated the role of Hh activity in crafting a hypoxic environment of breast cancer. We used radioactive tracer [

Indexed as

AnimalsEvaluation Studies as TopicFemaleHedgehog ProteinsHumansLongitudinal StudiesMicePositron-Emission TomographyTransfectionTumor HypoxiaHedgehog Proteins

Identifiers

PMID34593607
PMCPMC8738112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.